New scan could solve mystery of hidden cancer origins
NCT ID NCT07372963
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a special type of PET/CT scan called 18F-FAPI to see if it can better find where a cancer started when the original source is unknown. About 120 people with cancer of unknown primary will receive the scan, and researchers will measure how accurate it is at detecting the tumor's origin. The goal is to improve diagnosis and help guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER OF UNKNOWN PRIMARY SITE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug boost chemotherapy against mysterious cancers?
- Rare cancer hope: genetic tests may match patients to better treatments
- Immunotherapy drug tested for mysterious cancers
- New trial aims to solve the mystery of cancers with unknown origins
- New hope for mystery cancers: immunotherapy shows promise
- Gene-Guided therapy may outperform chemo for mysterious cancers